explore -WSS

explore

author：focus 2025-09-06 01:57:54 - browse：4464

A pharmacy technician prepares prescriptions for packaging and shipping after being filled. health policy coverage from STAT — George Frey/Getty Images

WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing question is how.

The White House and a whole host of government agencies oversee programs aimed at mitigating drug shortages, including the Food and Drug Administration, the Administration for Strategic Preparedness and Response, the White House Office of Science and Technology Policy, the Department of Defense, and the Department of Commerce.

The White House also has a new task force that is supposed to put together recommendations for fighting drug shortages, one it formed early this year in response to news of the worsening drug shortage crisis as the country began running out of an increasing number of chemotherapies. It has met with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm solutions, but it’s not clear what it has in mind or when it will make those recommendations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： ReNAgade cuts staff seven months after raising $300 million

leisure time

WSS

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

J&J to emphasize cancer drugs, stop much of its vaccine research

Liver decline slowed by off

UnitedHealth argues against case alleging wrongful AI care denials

At flashy new research hub, AstraZeneca lays out ambitious growth goals

ASCO eve: Let’s set the table for this year's meeting

focus

explore

Wikipedia

The high cost of giving birth even with insurance

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

BIO selects John Crowley as new CEO

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Fetal surgery at risk from Dobbs and new abortion restrictions

Medicare details structure of new drug price negotiation program

Reports of telehealth's death have been greatly exaggerated

Virginia high school admissions case could be legal follow

Citing H5N1 threat, CDC urges peak flu monitoring this summer

leisure time

For longer

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Investigation reveals sickle cell patients pressured into sterilizations

Listen: More tumult at BIO & coercive care for sickle cell patients

With clinical trial data readouts, here's how to spot spin

J&J to emphasize cancer drugs, stop much of its vaccine research

Wikipedia

leisure time

hotspot

entertainment